Literature DB >> 10831388

Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.

S P Nickell1, D Sharma.   

Abstract

CD8+ T cells have been shown to be required for acute resistance to infection with the protozoan parasite, Trypanosoma cruzi, the causative agent of Chagas' disease. However, to date, the mechanism by which CD8+ T cells mediate protection in vivo has not been determined. While CD8+ T cells can exhibit cytolytic function, they also secrete cytokines such as IFN-gamma, which is known to mediate protection against T. cruzi infections. To determine whether cytolysis is an important effector function in vivo, we have compared outcomes of T. cruzi infection in normal and perforin-deficient mice. Our results indicate that while perforin-dependent cytolytic mechanisms clearly make a major contribution to acute resistance to T. cruzi infection, this contribution may be strain and challenge dose-dependent, since perforin-deficient mice challenged with lower doses of a less virulent strain survived and were subsequently resistant to challenge with virulent organisms. In vivo depletion studies demonstrated that survival of perforin-deficient mice challenged with low doses of T. cruzi requires both CD4+ and CD8+ T cells and is dependent on IFN-gamma secretion. These studies document the participation of both perforin-dependent cytotoxic and perforin-independent, IFN-gamma-dependent immune mechanisms in acute resistance to T. cruzi infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831388     DOI: 10.1006/expr.2000.4498

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  13 in total

Review 1.  Apoptosis and the balance of homeostatic and pathologic responses to protozoan infection.

Authors:  L Cristina Gavrilescu; Eric Y Denkers
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection.

Authors:  Andrea Henriques-Pons; Gabriel M Oliveira; Mauricio M Paiva; Alexandre F S Correa; Marcos M Batista; Rodrigo C Bisaggio; Chau-Ching Liu; Vinicius Cotta-De-Almeida; Claudia M L M Coutinho; Pedro M Persechini; Tania C Araujo-Jorge
Journal:  Int J Exp Pathol       Date:  2002-04       Impact factor: 1.925

3.  Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.

Authors:  Fanny Tzelepis; Bruna C G de Alencar; Marcus L O Penido; Ricardo T Gazzinelli; Pedro M Persechini; Mauricio M Rodrigues
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

4.  Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.

Authors:  Jaline Coutinho Silverio; Luzia Maria de-Oliveira-Pinto; Andréa Alice da Silva; Gabriel Melo de Oliveira; Joseli Lannes-Vieira
Journal:  Int J Exp Pathol       Date:  2009-10-28       Impact factor: 1.925

5.  NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi.

Authors:  Thomas Jacobs; Heike Bruhn; Iris Gaworski; Bernhard Fleischer; Matthias Leippe
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

6.  Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.

Authors:  Masaharu Katae; Yasushi Miyahira; Kazuyoshi Takeda; Hironori Matsuda; Hideo Yagita; Ko Okumura; Tsutomu Takeuchi; Tsuneo Kamiyama; Akihiko Ohwada; Yoshinosuke Fukuchi; Takashi Aoki
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

7.  Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferon-gamma production during experimental infection with Trypanosoma cruzi.

Authors:  C Une; J Andersson; A Orn
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

8.  Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice.

Authors:  Kara L Cummings; Rick L Tarleton
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.

Authors:  Shivali Gupta; Nisha J Garg
Journal:  PLoS Pathog       Date:  2015-05-07       Impact factor: 6.823

10.  The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice.

Authors:  Luiz Roberto Sardinha; Tainá Mosca; Rosa Maria Elias; Rogério Silva do Nascimento; Lígia A Gonçalves; Daniella Zanetti Bucci; Cláudio Romero Farias Marinho; Carlos Penha-Gonçalves; Maria Regina D'Império Lima; José Maria Alvarez
Journal:  PLoS Negl Trop Dis       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.